
LINK . SPRINGER . COM {
}
Title:
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial | Cancer Immunology, Immunotherapy
Description:
Background Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms. Cisplatin has shown immunomodulatory effects in vivo which may enhance efficacy of DC vaccination. Methods This is a prospective, randomized, open-label phase 2 study (NCT02285413) including stage III and IV melanoma patients receiving 3 biweekly vaccinations of gp100 and tyrosinase mRNA-loaded monocyte-derived DCs with or without cisplatin. Primary objectives were to study immunogenicity and feasibility, and secondary objectives were to assess toxicity and survival. Results Twenty-two stage III and 32 stage IV melanoma patients were analyzed. Antigen-specific CD8+ T cells were found in 44% versus 67% and functional T cell responses in 28% versus 19% of skin-test infiltrating lymphocytes in patients receiving DC vaccination with and without cisplatin, respectively. Four patients stopped cisplatin because of toxicity and continued DC monotherapy. No therapy-related grade 3 or 4 adverse events occurred due to DC monotherapy. During combination therapy, one therapy-related grade 3 adverse event, decompensated heart failure due to fluid overload, occurred. The clinical outcome parameters did not clearly suggest significant differences. Conclusions Combination of DC vaccination and cisplatin in melanoma patients is feasible and safe, but does not seem to result in more tumor-specific T cell responses or improved clinical outcome, when compared to DC vaccination monotherapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {🔍}
patients, cells, melanoma, stage, cisplatin, vaccination, cell, article, google, scholar, iii, combination, tumor, treatment, cancer, responses, monotherapy, group, dendritic, fig, clinical, immune, response, cas, medical, trial, dcs, autologous, tissue, analysis, tyrosinase, compared, months, disease, research, van, effects, study, survival, adverse, therapy, proliferation, performed, klh, supplementary, skils, university, found, events, immunological,
Topics {✒️}
dendritic-cell based immunotherapy—focusing hla-dr−cd14+cd11b+cd33+ cells skin-test infiltrating lymphocytes autologous epstein–barr virus cis-dichlorodiammine-platinum versus dacarbazine formalin-fixed paraffin-embedded tumor-induced immune suppression skin-test infiltrating lymphocyte dendritic cell-based vaccination dendritic cell immunotherapy antibody-tsa complex removals ficoll-paque density centrifugation cd3+cd4+cd25+foxp3+ cells efficient antigen-presenting cells myeloid-derived suppressor cells tjitske duiveman-de boer effective anti-pd-1 mabs autologous dc vaccines clinical-grade dendritic cells phorbol myristate acetate-stimulated article download pdf conventional therapeutic interventions anti-hla-dr-bv510 antigen-specific t-cells anti-hla-dr-pe sided log-rank test anti-tumor immune response anti-hla-abc-pe anti-hla-dq-pe anna de goede common terminology criteria full access hla-type independent monitoring dc dendritic cell dendritic cell vaccination cisplatin-induced antitumor immunomodulation common adverse events keyhole limpet hemocyanin opal reagent incubations 5 ng/ml il-1β induce tumor-specific frequent adverse events adverse events leading melanoma-related death tumor antigen-specific chemo-immunotherapy strategies autologous dc vaccination privacy choices/manage cookies additional information publisher' primary antibody incubations
Schema {🗺️}
WebPage:
mainEntity:
headline:Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
description:Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms. Cisplatin has shown immunomodulatory effects in vivo which may enhance efficacy of DC vaccination. This is a prospective, randomized, open-label phase 2 study (NCT02285413) including stage III and IV melanoma patients receiving 3 biweekly vaccinations of gp100 and tyrosinase mRNA-loaded monocyte-derived DCs with or without cisplatin. Primary objectives were to study immunogenicity and feasibility, and secondary objectives were to assess toxicity and survival. Twenty-two stage III and 32 stage IV melanoma patients were analyzed. Antigen-specific CD8+ T cells were found in 44% versus 67% and functional T cell responses in 28% versus 19% of skin-test infiltrating lymphocytes in patients receiving DC vaccination with and without cisplatin, respectively. Four patients stopped cisplatin because of toxicity and continued DC monotherapy. No therapy-related grade 3 or 4 adverse events occurred due to DC monotherapy. During combination therapy, one therapy-related grade 3 adverse event, decompensated heart failure due to fluid overload, occurred. The clinical outcome parameters did not clearly suggest significant differences. Combination of DC vaccination and cisplatin in melanoma patients is feasible and safe, but does not seem to result in more tumor-specific T cell responses or improved clinical outcome, when compared to DC vaccination monotherapy.
datePublished:2020-01-24T00:00:00Z
dateModified:2020-01-24T00:00:00Z
pageStart:477
pageEnd:488
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-019-02466-x
keywords:
Dendritic cell
Vaccination
Cisplatin
Melanoma
Immunotherapy
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig3_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:69
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Steve Boudewijns
url:http://orcid.org/0000-0003-4201-3507
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Martine Bloemendal
url:http://orcid.org/0000-0001-9395-4214
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Nienke de Haas
url:http://orcid.org/0000-0002-4082-0498
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Harm Westdorp
url:http://orcid.org/0000-0002-3336-4164
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Kalijn F. Bol
url:http://orcid.org/0000-0003-4165-2040
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Gerty Schreibelt
url:http://orcid.org/0000-0002-0156-8365
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Erik H. J. G. Aarntzen
url:http://orcid.org/0000-0002-3809-0182
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center
address:
name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:W. Joost Lesterhuis
url:http://orcid.org/0000-0002-2718-276X
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:University of Western Australia
address:
name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
type:PostalAddress
type:Organization
type:Person
name:Mark A. J. Gorris
url:http://orcid.org/0000-0003-3621-226X
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Alexandra Croockewit
affiliation:
name:Radboud University Medical Center
address:
name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Lieke L. van der Woude
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center
address:
name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Michelle M. van Rossum
affiliation:
name:Radboud University Medical Center
address:
name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Marieke Welzen
affiliation:
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Anna de Goede
affiliation:
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Stanleyson V. Hato
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Winette T. A. van der Graaf
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Cornelis J. A. Punt
url:http://orcid.org/0000-0003-0846-1445
affiliation:
name:University of Amsterdam
address:
name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Rutger H. T. Koornstra
url:http://orcid.org/0000-0002-5446-755X
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Rijnstate Hospital
address:
name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Winald R. Gerritsen
url:http://orcid.org/0000-0003-1110-9119
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Carl G. Figdor
url:http://orcid.org/0000-0002-2366-9212
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:I. Jolanda M. de Vries
url:http://orcid.org/0000-0002-8653-4040
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
description:Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms. Cisplatin has shown immunomodulatory effects in vivo which may enhance efficacy of DC vaccination. This is a prospective, randomized, open-label phase 2 study (NCT02285413) including stage III and IV melanoma patients receiving 3 biweekly vaccinations of gp100 and tyrosinase mRNA-loaded monocyte-derived DCs with or without cisplatin. Primary objectives were to study immunogenicity and feasibility, and secondary objectives were to assess toxicity and survival. Twenty-two stage III and 32 stage IV melanoma patients were analyzed. Antigen-specific CD8+ T cells were found in 44% versus 67% and functional T cell responses in 28% versus 19% of skin-test infiltrating lymphocytes in patients receiving DC vaccination with and without cisplatin, respectively. Four patients stopped cisplatin because of toxicity and continued DC monotherapy. No therapy-related grade 3 or 4 adverse events occurred due to DC monotherapy. During combination therapy, one therapy-related grade 3 adverse event, decompensated heart failure due to fluid overload, occurred. The clinical outcome parameters did not clearly suggest significant differences. Combination of DC vaccination and cisplatin in melanoma patients is feasible and safe, but does not seem to result in more tumor-specific T cell responses or improved clinical outcome, when compared to DC vaccination monotherapy.
datePublished:2020-01-24T00:00:00Z
dateModified:2020-01-24T00:00:00Z
pageStart:477
pageEnd:488
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-019-02466-x
keywords:
Dendritic cell
Vaccination
Cisplatin
Melanoma
Immunotherapy
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_Fig3_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:69
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Steve Boudewijns
url:http://orcid.org/0000-0003-4201-3507
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Martine Bloemendal
url:http://orcid.org/0000-0001-9395-4214
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Nienke de Haas
url:http://orcid.org/0000-0002-4082-0498
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Harm Westdorp
url:http://orcid.org/0000-0002-3336-4164
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Kalijn F. Bol
url:http://orcid.org/0000-0003-4165-2040
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Gerty Schreibelt
url:http://orcid.org/0000-0002-0156-8365
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Erik H. J. G. Aarntzen
url:http://orcid.org/0000-0002-3809-0182
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center
address:
name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:W. Joost Lesterhuis
url:http://orcid.org/0000-0002-2718-276X
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:University of Western Australia
address:
name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
type:PostalAddress
type:Organization
type:Person
name:Mark A. J. Gorris
url:http://orcid.org/0000-0003-3621-226X
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Alexandra Croockewit
affiliation:
name:Radboud University Medical Center
address:
name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Lieke L. van der Woude
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center
address:
name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Michelle M. van Rossum
affiliation:
name:Radboud University Medical Center
address:
name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Marieke Welzen
affiliation:
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Anna de Goede
affiliation:
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Stanleyson V. Hato
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Winette T. A. van der Graaf
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Cornelis J. A. Punt
url:http://orcid.org/0000-0003-0846-1445
affiliation:
name:University of Amsterdam
address:
name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Rutger H. T. Koornstra
url:http://orcid.org/0000-0002-5446-755X
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Rijnstate Hospital
address:
name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Winald R. Gerritsen
url:http://orcid.org/0000-0003-1110-9119
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Carl G. Figdor
url:http://orcid.org/0000-0002-2366-9212
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:I. Jolanda M. de Vries
url:http://orcid.org/0000-0002-8653-4040
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:69
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:University of Western Australia
address:
name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:University of Amsterdam
address:
name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Rijnstate Hospital
address:
name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Steve Boudewijns
url:http://orcid.org/0000-0003-4201-3507
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Martine Bloemendal
url:http://orcid.org/0000-0001-9395-4214
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Nienke de Haas
url:http://orcid.org/0000-0002-4082-0498
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Harm Westdorp
url:http://orcid.org/0000-0002-3336-4164
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Kalijn F. Bol
url:http://orcid.org/0000-0003-4165-2040
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Gerty Schreibelt
url:http://orcid.org/0000-0002-0156-8365
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Erik H. J. G. Aarntzen
url:http://orcid.org/0000-0002-3809-0182
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center
address:
name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:W. Joost Lesterhuis
url:http://orcid.org/0000-0002-2718-276X
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:University of Western Australia
address:
name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
type:PostalAddress
type:Organization
name:Mark A. J. Gorris
url:http://orcid.org/0000-0003-3621-226X
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Alexandra Croockewit
affiliation:
name:Radboud University Medical Center
address:
name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Lieke L. van der Woude
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center
address:
name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Michelle M. van Rossum
affiliation:
name:Radboud University Medical Center
address:
name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Marieke Welzen
affiliation:
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Anna de Goede
affiliation:
name:Radboud University Medical center
address:
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Stanleyson V. Hato
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Winette T. A. van der Graaf
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Cornelis J. A. Punt
url:http://orcid.org/0000-0003-0846-1445
affiliation:
name:University of Amsterdam
address:
name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
type:PostalAddress
type:Organization
name:Rutger H. T. Koornstra
url:http://orcid.org/0000-0002-5446-755X
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Rijnstate Hospital
address:
name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
type:PostalAddress
type:Organization
name:Winald R. Gerritsen
url:http://orcid.org/0000-0003-1110-9119
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Carl G. Figdor
url:http://orcid.org/0000-0002-2366-9212
affiliation:
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:I. Jolanda M. de Vries
url:http://orcid.org/0000-0002-8653-4040
affiliation:
name:Radboud University Medical Center
address:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
name:Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
address:
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:School of Biomedical Sciences, University of Western Australia, Crawley, Australia
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
name:Department of Pharmacy, Radboud University Medical center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Medical Oncology, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Oncological Center, Rijnstate Hospital, Arnhem, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
name:Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
name:Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
External Links {🔗}(155)
- Profit of https://www.springernature.com/gp/authors
- How much money does https://link.springernature.com/home/ make?
- How much cash flow does https://order.springer.com/public/cart have monthly?
- How much cash flow does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research have monthly?
- Learn about the earnings of https://submission.nature.com/new-submission/262/3
- How much does https://orcid.org/0000-0003-4201-3507 generate monthly?
- How much profit does https://orcid.org/0000-0001-9395-4214 make?
- Income figures for https://orcid.org/0000-0002-4082-0498
- What's the income generated by https://orcid.org/0000-0002-3336-4164 each month?
- https://orcid.org/0000-0003-4165-2040's total income per month
- How much money does https://orcid.org/0000-0002-0156-8365 generate?
- What's the monthly money flow for https://orcid.org/0000-0002-3809-0182?
- Get to know what's the income of https://orcid.org/0000-0002-2718-276X
- Profit of https://orcid.org/0000-0003-3621-226X
- What's the monthly money flow for https://orcid.org/0000-0003-0846-1445?
- Find out how much https://orcid.org/0000-0002-5446-755X earns monthly
- Income figures for https://orcid.org/0000-0003-1110-9119
- What's the revenue for https://orcid.org/0000-0002-2366-9212?
- How much revenue does https://orcid.org/0000-0002-8653-4040 produce monthly?
- Profit of https://beta.springernature.com/pre-submission?journalId=262
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Dendritic%20cell%20vaccination%20in%20the%20evolving%20therapeutic%20landscape%20of%20melanoma%2C%20departments%20of%20Tumor%20Immunology%20and%20Medical%20Oncology&publication_year=2017&author=Boudewijns%2CS produce monthly?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Novel%20strategies%20in%20dendritic-cell%20based%20immunotherapy%E2%80%94focusing%20on%20adjuvant%20treatment%20of%20stage%20III%20melanoma%2C%20departments%20of%20Tumor%20Immunology%20and%20Medical%20Oncology&publication_year=2019&author=Bloemendal%2CM
- https://doi.org/10.1016%2Fj.immuni.2013.07.004 income
- How much money does http://scholar.google.com/scholar_lookup?&title=Dendritic-cell-based%20therapeutic%20cancer%20vaccines&journal=Immunity&doi=10.1016%2Fj.immuni.2013.07.004&volume=39&issue=1&pages=38-48&publication_year=2013&author=Palucka%2CK&author=Banchereau%2CJ make?
- How much revenue does https://doi.org/10.1080%2F2162402X.2016.1191732 bring in?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Adjuvant%20dendritic%20cell%20vaccination%20induces%20tumor-specific%20immune%20responses%20in%20the%20majority%20of%20stage%20III%20melanoma%20patients&journal=Oncoimmunology&doi=10.1080%2F2162402X.2016.1191732&volume=5&issue=7&publication_year=2016&author=Boudewijns%2CS?
- How much income is https://doi.org/10.1158%2F1078-0432.CCR-11-3368 earning monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Vaccination%20with%20mRNA-electroporated%20dendritic%20cells%20induces%20robust%20tumor%20antigen-specific%20CD4%2B%20and%20CD8%2B%20T%20cells%20responses%20in%20stage%20III%20and%20IV%20melanoma%20patients&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-11-3368&volume=18&issue=19&pages=5460-5470&publication_year=2012&author=Aarntzen%2CEH makes per month
- How much does https://doi.org/10.1158%2F1078-0432.CCR-11-1261 bring in each month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Route%20of%20administration%20modulates%20the%20induction%20of%20dendritic%20cell%20vaccine-induced%20antigen-specific%20T%20cells%20in%20advanced%20melanoma%20patients&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-11-1261&volume=17&issue=17&pages=5725-5735&publication_year=2011&author=Lesterhuis%2CWJ
- Get to know https://doi.org/10.1097%2FCJI.0b013e31821dcb31's earnings
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20vaccination%20with%20an%20autologous%20mRNA%20electroporated%20dendritic%20cell%20vaccine%20in%20patients%20with%20advanced%20melanoma&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e31821dcb31&volume=34&issue=5&pages=448-456&publication_year=2011&author=Wilgenhof%2CS
- How much revenue does https://doi.org/10.1080%2F2162402X.2015.1057673 produce monthly?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Favorable%20overall%20survival%20in%20stage%20III%20melanoma%20patients%20after%20adjuvant%20dendritic%20cell%20vaccination&journal=Oncoimmunology&doi=10.1080%2F2162402X.2015.1057673&volume=5&issue=1&publication_year=2016&author=Bol%2CKF?
- See how much http://scholar.google.com/scholar_lookup?&title=Platinum-based%20drugs%3A%20past%2C%20present%20and%20future&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-016-2976-z&volume=77&issue=6&pages=1103-1124&publication_year=2016&author=Dilruba%2CS&author=Kalayda%2CGV makes per month
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=393385
- How much does http://scholar.google.com/scholar_lookup?&title=Cis-dichlorodiammineplatinum%28II%29%20alone%20and%20combined%20with%20DTIC%20for%20treatment%20of%20disseminated%20malignant%20melanoma&journal=Cancer%20Treat%20Rep&volume=63&issue=11%E2%80%9312&pages=2005-2007&publication_year=1979&author=Goodnight%2CJE earn?
- Earnings of https://doi.org/10.1200%2FJCO.1984.2.3.164
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Randomized%20phase%20III%20trial%20of%20vinblastine%2C%20bleomycin%2C%20and%20cis-dichlorodiammine-platinum%20versus%20dacarbazine%20in%20malignant%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.1984.2.3.164&volume=2&issue=3&pages=164-168&publication_year=1984&author=Luikart%2CSD&author=Kennealey%2CGT&author=Kirkwood%2CJM
- How much does https://doi.org/10.1200%2FJCO.1997.15.7.2579 pull in monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Interferon%20alfa-2a%20and%20interleukin-2%20with%20or%20without%20cisplatin%20in%20metastatic%20melanoma%3A%20a%20randomized%20trial%20of%20the%20European%20Organization%20for%20Research%20and%20Treatment%20of%20Cancer%20Melanoma%20Cooperative%20Group&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.1997.15.7.2579&volume=15&issue=7&pages=2579-2588&publication_year=1997&author=Keilholz%2CU produce monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20metastatic%20melanoma%3A%20an%20overview&journal=Oncology%20%28Williston%20Park%29&volume=23&issue=6&pages=488-496&publication_year=2009&author=Bhatia%2CS&author=Tykodi%2CSS&author=Thompson%2CJA
- How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-14-1298 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=Cisplatin-induced%20antitumor%20immunomodulation%3A%20a%20review%20of%20preclinical%20and%20clinical%20evidence&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-1298&volume=20&issue=21&pages=5384-5391&publication_year=2014&author=Biasi%2CAR&author=Villena-Vargas%2CJ&author=Adusumilli%2CPS makes per month
- How much money does https://doi.org/10.1158%2F1078-0432.CCR-13-3141 make?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Molecular%20pathways%3A%20the%20immunogenic%20effects%20of%20platinum-based%20chemotherapeutics&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-13-3141&volume=20&issue=11&pages=2831-2837&publication_year=2014&author=Hato%2CSV is on a monthly basis
- What's the monthly money flow for https://doi.org/10.18632%2Foncotarget.17661?
- How much does http://scholar.google.com/scholar_lookup?&title=Direct%20inhibition%20of%20STAT%20signaling%20by%20platinum%20drugs%20contributes%20to%20their%20anti-cancer%20activity&journal=Oncotarget&doi=10.18632%2Foncotarget.17661&volume=8&issue=33&pages=54434-54443&publication_year=2017&author=Hato%2CSV bring in each month?
- Revenue of https://doi.org/10.1038%2Fnm976
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20the%20innate%20and%20adaptive%20immune%20responses%20by%20Stat-3%20signaling%20in%20tumor%20cells&journal=Nat%20Med&doi=10.1038%2Fnm976&volume=10&issue=1&pages=48-54&publication_year=2004&author=Wang%2CT?
- What's the revenue for https://doi.org/10.1172%2FJCI43656?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Platinum-based%20drugs%20disrupt%20STAT6-mediated%20suppression%20of%20immune%20responses%20against%20cancer%20in%20humans%20and%20mice&journal=J%20Clin%20Investig&doi=10.1172%2FJCI43656&volume=121&issue=8&pages=3100-3108&publication_year=2011&author=Lesterhuis%2CWJ
- Get to know http://scholar.google.com/scholar_lookup?&title=Cisplatin%20selectively%20downregulated%20the%20frequency%20and%20immunoinhibitory%20function%20of%20myeloid-derived%20suppressor%20cells%20in%20a%20murine%20B16%20melanoma%20model&journal=Immunol%20Res&doi=10.1007%2Fs12026-015-8734-1&volume=64&issue=1&pages=160-170&publication_year=2016&author=Huang%2CX&author=Cui%2CS&author=Shu%2CY's earnings
- How much profit does https://doi.org/10.4161%2Fonci.27025 generate?
- How much income does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20conventional%20therapeutic%20interventions%20on%20the%20number%20and%20function%20of%20regulatory%20T%20cells&journal=Oncoimmunology&doi=10.4161%2Fonci.27025&volume=2&issue=10&publication_year=2013&author=Roselli%2CM have?
- https://doi.org/10.1080%2F2162402X.2016.1192739 income
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Human%20CD1c%28%2B%29%20DCs%20are%20critical%20cellular%20mediators%20of%20immune%20responses%20induced%20by%20immunogenic%20cell%20death&journal=Oncoimmunology&doi=10.1080%2F2162402X.2016.1192739&volume=5&issue=8&publication_year=2016&author=Blasio%2CS each month?
- Get to know what's the income of https://doi.org/10.1158%2F1078-0432.CCR-14-2142
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Vaccine-induced%20tumor%20necrosis%20factor-producing%20T%20cells%20synergize%20with%20cisplatin%20to%20promote%20tumor%20cell%20death&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-2142&volume=21&issue=4&pages=781-794&publication_year=2015&author=Sluis%2CTC?
- How much profit is https://doi.org/10.1200%2FJCO.2009.23.4799 making per month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Final%20version%20of%202009%20AJCC%20melanoma%20staging%20and%20classification&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.23.4799&volume=27&issue=36&pages=6199-6206&publication_year=2009&author=Balch%2CCM?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19653708 generate?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=The%207th%20edition%20AJCC%20staging%20system%20for%20eye%20cancer%3A%20an%20international%20language%20for%20ophthalmic%20oncology&journal=Arch%20Pathol%20Lab%20Med&volume=133&issue=8&pages=1197-1198&publication_year=2009&author=Finger%2CPT
- Profit of https://doi.org/10.1016%2FS0022-1759%2802%2900189-8
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Large-scale%20generation%20of%20mature%20monocyte-derived%20dendritic%20cells%20for%20clinical%20application%20in%20cell%20factories&journal=J%20Immunol%20Methods&doi=10.1016%2FS0022-1759%2802%2900189-8&volume=268&issue=2&pages=131-140&publication_year=2002&author=Berger%2CTG have monthly?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15585917
- How much does http://scholar.google.com/scholar_lookup?&title=Phenotypical%20and%20functional%20characterization%20of%20clinical-grade%20dendritic%20cells&journal=Methods%20Mol%20Med&volume=109&pages=113-126&publication_year=2005&author=Vries%2CIJ bring in each month?
- What's the financial intake of https://doi.org/10.1158%2F0008-5472.CAN-08-3920?
- How much does http://scholar.google.com/scholar_lookup?&title=In%20situ%20expression%20of%20tumor%20antigens%20by%20messenger%20RNA-electroporated%20dendritic%20cells%20in%20lymph%20nodes%20of%20melanoma%20patients&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-3920&volume=69&issue=7&pages=2927-2934&publication_year=2009&author=Schuurhuis%2CDH make?
- How much profit does https://doi.org/10.1038%2Fnm1039 generate?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Dendritic%20cell%20immunotherapy%3A%20mapping%20the%20way&journal=Nat%20Med&doi=10.1038%2Fnm1039&volume=10&issue=5&pages=475-480&publication_year=2004&author=Figdor%2CCG earns monthly
- What's the financial gain of https://doi.org/10.1158%2F0008-5472.CAN-12-2479?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Skin-test%20infiltrating%20lymphocytes%20early%20predict%20clinical%20outcome%20of%20dendritic%20cell-based%20vaccination%20in%20metastatic%20melanoma&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-12-2479&volume=72&issue=23&pages=6102-6110&publication_year=2012&author=Aarntzen%2CEH?
- How much does https://doi.org/10.1200%2FJCO.2005.06.478 pull in?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Immunomonitoring%20tumor-specific%20T%20cells%20in%20delayed-type%20hypersensitivity%20skin%20biopsies%20after%20dendritic%20cell%20vaccination%20correlates%20with%20clinical%20outcome&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.06.478&volume=23&issue=24&pages=5779-5787&publication_year=2005&author=Vries%2CIJ?
- How much money does https://doi.org/10.1016%2Fj.jim.2011.12.010 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Epitope%20and%20HLA-type%20independent%20monitoring%20of%20antigen-specific%20T-cells%20after%20treatment%20with%20dendritic%20cells%20presenting%20full-length%20tumor%20antigens&journal=J%20Immunol%20Methods&doi=10.1016%2Fj.jim.2011.12.010&volume=377&issue=1%E2%80%932&pages=23-36&publication_year=2012&author=Nuffel%2CAM generate?
- Earnings of https://doi.org/10.1080%2F2162402X.2015.1066062
- How much profit does http://scholar.google.com/scholar_lookup?&title=Dexamethasone%20co-medication%20in%20cancer%20patients%20undergoing%20chemotherapy%20causes%20substantial%20immunomodulatory%20effects%20with%20implications%20for%20chemo-immunotherapy%20strategies&journal=Oncoimmunology&doi=10.1080%2F2162402X.2015.1066062&volume=5&issue=3&publication_year=2016&author=Cook%2CAM generate?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Regulatory%20effects%20of%20dexamethasone%20on%20NK%20and%20T%20cell%20immunity&journal=Inflammopharmacology&doi=10.1007%2Fs10787-017-0418-0&volume=26&issue=5&pages=1331-1338&publication_year=2018&author=Chen%2CL&author=Jondal%2CM&author=Yakimchuk%2CK?
- What's the financial intake of https://doi.org/10.1126%2Fscitranslmed.aad8307?
- http://scholar.google.com/scholar_lookup?&title=Vaccination%20during%20myeloid%20cell%20depletion%20by%20cancer%20chemotherapy%20fosters%20robust%20T%20cell%20responses&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.aad8307&volume=8&issue=334&publication_year=2016&author=Welters%2CMJ's financial summary
- Revenue of https://doi.org/10.1158%2F1078-0432.CCR-09-1254
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Dendritic%20cell%20vaccination%20combined%20with%20CTLA4%20blockade%20in%20patients%20with%20metastatic%20melanoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-1254&volume=15&issue=19&pages=6267-6276&publication_year=2009&author=Ribas%2CA
- Earnings of https://doi.org/10.1038%2Fnature13954
- What's http://scholar.google.com/scholar_lookup?&title=PD-1%20blockade%20induces%20responses%20by%20inhibiting%20adaptive%20immune%20resistance&journal=Nature&doi=10.1038%2Fnature13954&volume=515&issue=7528&pages=568-571&publication_year=2014&author=Tumeh%2CPC's gross income?
- What's the income of https://doi.org/10.1016%2Fj.vaccine.2015.10.057?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Checkpoint%20blockade%20in%20combination%20with%20cancer%20vaccines&journal=Vaccine&doi=10.1016%2Fj.vaccine.2015.10.057&volume=33&issue=51&pages=7377-7385&publication_year=2015&author=Morse%2CMA&author=Lyerly%2CHK is on a monthly basis
- How much money does https://doi.org/10.1200%2FJCO.2015.63.4121 generate?
- Get to know http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20autologous%20monocyte-derived%20mRNA%20electroporated%20dendritic%20cells%20%28TriMixDC-MEL%29%20plus%20ipilimumab%20in%20patients%20with%20pretreated%20advanced%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2015.63.4121&volume=34&issue=12&pages=1330-1338&publication_year=2016&author=Wilgenhof%2CS's earnings
- How much does https://doi.org/10.3389%2Ffimmu.2018.02265 rake in every month?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Dendritic%20cell%20cancer%20therapy%3A%20vaccinating%20the%20right%20patient%20at%20the%20right%20time&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2018.02265&volume=9&publication_year=2018&author=Willigen%2CWW
- What's the monthly income of https://citation-needed.springer.com/v2/references/10.1007/s00262-019-02466-x?format=refman&flavour=references?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Steve%20Boudewijns pull in monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Steve%20Boudewijns%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Martine%20Bloemendal?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Martine%20Bloemendal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nienke%20de%20Haas earns monthly
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nienke%20de%20Haas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Harm%20Westdorp?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Harm%20Westdorp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kalijn%20F.%20Bol
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kalijn%20F.%20Bol%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gerty%20Schreibelt produce monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gerty%20Schreibelt%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Erik%20H.%20J.%20G.%20Aarntzen's revenue stream
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Erik%20H.%20J.%20G.%20Aarntzen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=W.%20Joost%20Lesterhuis
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22W.%20Joost%20Lesterhuis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mark%20A.%20J.%20Gorris bring in each month?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mark%20A.%20J.%20Gorris%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexandra%20Croockewit each month?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexandra%20Croockewit%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lieke%20L.%20van%20der%20Woude
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lieke%20L.%20van%20der%20Woude%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michelle%20M.%20van%20Rossum
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michelle%20M.%20van%20Rossum%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marieke%20Welzen each month?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marieke%20Welzen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anna%20de%20Goede each month?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anna%20de%20Goede%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stanleyson%20V.%20Hato making per month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stanleyson%20V.%20Hato%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Winette%20T.%20A.%20van%20der%20Graaf earn?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Winette%20T.%20A.%20van%20der%20Graaf%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cornelis%20J.%20A.%20Punt?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cornelis%20J.%20A.%20Punt%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rutger%20H.%20T.%20Koornstra earn?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rutger%20H.%20T.%20Koornstra%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Winald%20R.%20Gerritsen's gross income?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Winald%20R.%20Gerritsen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carl%20G.%20Figdor
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carl%20G.%20Figdor%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=I.%20Jolanda%20M.%20de%20Vries
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22I.%20Jolanda%20M.%20de%20Vries%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Earnings of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-019-02466-x/MediaObjects/262_2019_2466_MOESM1_ESM.pdf
- How much does http://creativecommons.org/licenses/by/4.0/ net monthly?
- What's the financial gain of https://s100.copyright.com/AppDispatchServlet?title=Autologous%20monocyte-derived%20DC%20vaccination%20combined%20with%20cisplatin%20in%20stage%20III%20and%20IV%20melanoma%20patients%3A%20a%20prospective%2C%20randomized%20phase%202%20trial&author=Steve%20Boudewijns%20et%20al&contentID=10.1007%2Fs00262-019-02466-x©right=The%20Author%28s%29&publication=0340-7004&publicationDate=2020-01-24&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY?
- What's the income of https://crossmark.crossref.org/dialog/?doi=10.1007/s00262-019-02466-x?
- Discover the revenue of https://citation-needed.springer.com/v2/references/10.1007/s00262-019-02466-x?format=refman&flavour=citation
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral gross monthly?
- What's the monthly money flow for https://www.springernature.com/gp/products?
- How profitable is https://www.springernature.com/gp/librarians?
- How much does https://www.springernature.com/gp/societies earn?
- Learn about the earnings of https://www.springernature.com/gp/partners
- What's the total monthly financial gain of https://www.springer.com/?
- Discover the revenue of https://www.nature.com/
- What's the revenue for https://www.biomedcentral.com/?
- https://www.palgrave.com/'s financial summary
- How much profit does https://www.apress.com/ generate?
- https://www.springernature.com/gp/legal/ccpa income
- What's the total monthly financial gain of https://www.springernature.com/gp/info/accessibility?
- Financial intake of https://support.springernature.com/en/support/home
- What are the total earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- https://www.springernature.com/ income
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref